Patent EP0640596A1 successfully refreshed from Google Patents.
← Back to Patent Explorer
EP0640596A1 Expired / Lapsed EP ⏱️ 0.0 years remaining

N-pyridazinyl-benzene (naphthalene-, biphenyl-) sulfonamide derivatives, their preparation and their use as endothelin antagonists

Assignee: Bristol Myers Squibb Co
•
Filing: 1994-08-25
•
Granted: —
•
Expires: 2014-08-25
📄 Original PDF 🌐 Google Patents 🔄 Sync Now

Abstract

Abstract Compounds of the formula wherein: R is phenyl, naphthyl or biphenyl, each of which may be substituted with R¹, R² and R³; R⁴,R⁵ and R¹² are each independently (a) hydrogen; (b) alkyl, alkenyl, alkynyl, alkoxy, cycloalkyl, cycloalkylalkyl, cycloalkenyl, cycloalkenylalkyl, aryl, aryloxy, aralkyl or aralkoxy, any of which may be substituted with Z¹, Z² and Z³; (c) halo; (d) hydroxyl; (e) cyano; (f) nitro; (g) -C(O)H or -C(O)R⁶; (h) -CO₂H or -CO₂R⁶; (i) -SH, -S(O) n R⁶, -S(O) m -OH, -S(O) m -OR⁶, -O-S(O) m -R⁶, -O-S(O) m OH or -O-S(O) m -OR⁶; (j) -Z⁴-NR⁷R⁸; (k) -Z⁴-N(R¹¹)-Z⁵-NR⁹R¹⁰; or (l) R⁴ and R⁵ or R⁵ and R¹² together are alkylene or alkenylene (either of which may be substituted with Z¹, Z² and Z³), completing a 4- to 8-membered saturated, unsaturated or aromatic ring together with the carbon atoms to which they are attached; provided that when R is phenyl, at least two of R⁴, R⁵ and R¹² are other than hydrogen; R¹, R², R³, R⁶, R⁷, R⁸, R⁹, R¹⁰, R¹¹, Z¹, Z², Z³, Z⁴, Z⁵, n and m are as defined in the description; and pharmaceutically acceptable salts thereof are endothelin receptor antagonists useful, inter alia , as antihypertensive agents.

Inventors

  • 👤 John T. Hunt

Bibliographic Details

Application Number —
Jurisdiction EP
Data Source google_patents
Last Synchronized 2026-10-25 22:22
CPC Classifications
C; C07; C07D; C07D237/00; C07D237/02; C07D237/06; C07D237/10; C07D237/20; A; A61; A61K; A61K31/00; A61K31/33; A61K31/395; A61K31/495; A61K31/50; A61P; A61P13/00; A61P13/02; A61P15/00; A61P43/00; A61P9/00; A61P9/10; A61P9/12

Claims Analysis

Total Claims: 20
Claim 1
Independent Claim 849 words
A compound of the formula or such a compound in pharmaceutically acceptable salt form, wherein: R is phenyl, naphthyl or biphenyl, each of which may be substituted with R¹, R² and R³; R¹, R² and R³ are each independently (a) hydrogen; (b) alkyl, alkenyl, alkynyl, alkoxy, cycloalkyl, cycloalkylalkyl, cycloalkenyl, cycloalkenylalkyl, aryl, aryloxy, aralkyl or aralkoxy, any of which may be substituted with Z¹, Z² and Z³; (c) halo; (d) hydroxyl; (e) cyano; (f) nitro; (g) -C(O)H or -C(O)R⁶; (h) -CO₂H or -CO₂R⁶; (i) -SH, -S(O) n R⁶, -S(O) m -OH, -S(O) m -OR⁶, O-S(O) m -R⁶ -O-S(O) m OH or -O-S(O) m -OR⁶; (j) -Z⁴-NR⁷R⁸; or (k) -Z⁴-N(R¹¹)-Z⁵-NR⁹R¹⁰; R⁴, R⁵ and R¹² are each independently (a) hydrogen; (b) alkyl, alkenyl, alkynyl, alkoxy, cycloalkyl, cycloalkylalkyl, cycloalkenyl, cycloalkenylalkyl, aryl, aryloxy, aralkyl or aralkoxy, any of which may be substituted with Z¹, Z² and Z³; (c) halo; (d) hydroxyl; (e) cyano; (f) nitro; (g) -C(O)H or -C(O)R⁶; (h) -CO₂H or -CO₂R⁶; (i) -SH, -S(O) n R⁶, -S(O) m -OH, -S(O) m -OR⁶, -O-S(O) m -R⁶, -O-S(O) m OH or -O-S(O) m -OR⁶; (j) -Z⁴-NR⁷R⁸; (k) -Z⁴-N(R¹¹)-Z⁵-NR⁹R¹⁰; or (l) R⁴ and R⁵, or R⁵ and R¹² together are alkylene or alkenylene (either of which may be substituted with Z¹, Z² and Z³), completing a 4- to 8-membered saturated, unsaturated or aromatic ring together with the carbon atoms to which they are attached; provided that when R is phenyl, at least two of R⁴, R⁵ and R¹² are other than hydrogen; R⁶ is alkyl, alkenyl, alkynyl, alkoxy, cycloalkyl, cycloalkylalkyl, cycloalkenyl, cycloalkenylalkyl, aryl or aralkyl, any of which may be substituted with Z¹, Z² and Z³; R⁷ is (a) hydrogen; (b) alkyl, alkenyl, alkynyl, alkoxy, cycloalkyl, cycloalkylalkyl, cycloalkenyl, cycloalkenylalkyl, aryl or aralkyl, any of which may be substituted with Z¹, Z² and Z³; (c) cyano; (d) hydroxyl; (e) -C(O)H or -C(O)R⁶; (f) -CO₂R⁶; or (g) -SH, -S(O) n R⁶, -S(O) m -OR⁶, -O-S(O) m -R⁶ or -O-S(O) m -OR⁶, except when Z⁴ is -S(O) n -; R⁸ is (a) hydrogen; (b) -C(O)H or -C(O)R⁶, except when Z⁴ is -C(O)- and R⁷ is -C(O)H, -C(O)R⁶ or -CO₂R⁶; or (c) alkyl, alkenyl, alkynyl, alkoxy, cycloalkyl, cycloalkylalkyl, cycloalkenyl, cycloalkenylalkyl, aryl or aralkyl, any of which may be substituted with Z¹, Z² and Z³; or R⁷ and R⁸ together are alkylene or alkenylene (either of which may be substituted with Z¹, Z² and Z³), completing a 3- to 8- membered saturated, unsaturated or aromatic ring together with the nitrogen atom to which they are attached; R⁹ is (a) hydrogen; (b) hydroxyl; (c) -C(O)H or -C(O)R⁶; (d) -CO₂R⁶; (e) -SH, -S(O) n R⁶, -S(O) m -OR⁶, -O-S(O) m -R⁶ or -O-S(O) m -OR⁶; or (f) alkyl, alkenyl, alkynyl, alkoxy, cycloalkyl, cycloalkylalkyl, cycloalkenyl, cycloalkenylalkyl, aryl or aralkyl, any of which may be substituted with Z¹, Z² and Z³; R¹⁰ is (a) hydrogen; (b) -C(O)H or -C(O)R⁶, except when Z⁵ is -C(O)- and R⁹ is -C(O)H, -C(O)R⁶ or -CO₂R⁶; or (c) alkyl, alkenyl, alkynyl, alkoxy, cycloalkyl, cycloalkylalkyl, cycloalkenyl, cycloalkenylalkyl, aryl or aralkyl, any of which may be substituted with Z¹, Z² and Z³; R¹¹ is (a) hydrogen; (b) hydroxyl or -CO₂R⁶, except when one of R⁹ and R¹⁰ is hydroxyl or -CO₂R⁶; (c) -C(O)H or -C(O)R⁶; or (d) alkyl, alkenyl, alkynyl, alkoxy, cycloalkyl, cycloalkylalkyl, cycloalkenyl, cycloalkenylalkyl, aryl or aralkyl, any of which may be substituted with Z¹, Z² and Z³; or any two of R⁹, R¹⁰ and R¹¹ together are alkylene or alkenylene (either of which may be substituted with Z¹, Z² and Z³), completing a 3- to 8-membered saturated, unsaturated or aromatic ring together with the atoms to which they are attached; Z¹, Z² and Z³ are each independently (a) hydrogen; (b) halo; (c) hydroxy; (d) alkyl, alkenyl, aralkyl, alkoxy, aryloxy or aralkoxy; (e) -SH, -S(O) n Z⁶, -S(O) m -OH, -S(O) m -OZ⁶, -O-S(O) m -Z⁶, -O-S(O) m OH or -O-S(O) m -OZ⁶; (f) oxo; (g) nitro; (h) cyano; (i) -C(O)H or -C(O)Z⁶; (j) -CO₂H or -CO₂Z⁶; or (k) -Z⁴-NZ⁷Z⁸, Z⁴-N(Z¹¹)-Z⁵Z⁶ or -Z⁴-N(Z¹¹)-Z⁵-NZ⁷Z⁸; Z⁴ and Z⁵ are each independently (a) a single bond; (b) -Z⁹-S(O) m -Z¹⁰; (c) -Z⁹-C(O)-Z¹⁰; (d) -Z⁹-C(S)-Z¹⁰; (e) -Z⁹-O-Z¹⁰; (f) -Z⁹-S-Z¹⁰; (g) -Z⁹-O-C(O)-Z¹⁰; or (h) alkyl, alkenyl, alkynyl, cycloalkyl, cycloalkylalkyl, cycloalkenyl, cycloalkenylalkyl, aryl or aralkyl, any of which may be substituted with Z¹, Z² and Z³; Z⁶, Z⁷ and Z⁸ are each independently hydrogen, alkyl, alkenyl, alkynyl, cycloalkyl, cycloalkylalkyl, cycloalkenyl, cycloalkenylalkyl, aryl, or aralkyl, or Z⁷ and Z⁸ together are alkylene or alkenylene, completing a 3- to 8-membered saturated, unsaturated or aromatic ring together with the nitrogen atom to which they are attached; Z⁹ and Z¹⁰ are each independently a single bond, alkylene, alkenylene or alkynylene, Z¹¹ is (a) hydrogen; (b) hydroxyl; (c) -C(O)H, -C(O)Z⁶ or -CO₂Z⁶, provided that when Z¹¹ is -CO₂Z⁶, Z⁶ is other than hydrogen; or (d) alkyl, alkenyl, alkynyl, alkoxy, cycloalkyl, cycloalkylalkyl, cycloalkenyl, cycloalkenylalkyl, aryl or aralkyl; or any two of Z⁷, Z⁸ and Z¹¹ together are alkylene or alkenylene, completing a 3- to 8- membered saturated, unsaturated or aromatic ring together with the atoms to which they are attached; m is 1 or 2; and n is 0, 1 or 2.
Claim 2
Dependent Claim 829 words
A compound of the formula or such a compound in pharmaceutically acceptable salt form, wherein: R is naphthyl or biphenyl, each of which may be substituted with R¹, R² and R³; R¹, R² and R³ are each independently (a) hydrogen; (b) alkyl, alkenyl, alkynyl, alkoxy, cycloalkyl, cycloalkylalkyl, cycloalkenyl, cycloalkenylalkyl, aryl, aryloxy, aralkyl or aralkoxy, any of which may be substituted with Z¹, Z² and Z³; (c) halo; (d) hydroxyl; (e) cyano; (f) nitro; (g) -C(O)H or -C(O)R⁶; (h) -CO₂H or -CO₂R⁶; (i) -SH, -S(O) n R⁶, -S(O) m -OH, -S(O) m -OR⁶, -O-S(O) m -R⁶, -O-S(O) m OH or -O-S(O) m -OR⁶; (j) -Z⁴-NR⁷R⁸; or (k) -Z⁴-N(R¹¹)-Z⁵-NR⁹R¹⁰; R⁴, R⁵ and R¹² are each independently (a) hydrogen; (b) alkyl, alkenyl, alkynyl, alkoxy, cycloalkyl, cycloalkylalkyl, cycloalkenyl, cycloalkenylalkyl, aryl, aryloxy, aralkyl or aralkoxy, any of which may be substituted with Z¹, Z² and Z³; (c) halo; (d) hydroxyl; (e) cyano; (f) nitro; (g) -C(O)H or -C(O)R⁶; (h) -CO₂H or -CO₂R⁶; (i) -SH, -S(O) n R⁶, S(O) m -OH, -S(O) m -OR⁶, -O-S(O) m -R⁶, -O-S(O) m OH or -O-S(O) m -OR⁶; (j) -Z⁴-NR⁷R⁸; (k) -Z⁴-N(R¹¹)-Z⁵-NR⁹R¹⁰; or (l) R⁴ and R⁵, or R⁵ and R¹² together are alkylene or alkenylene (either of which may be substituted with Z¹, Z² and Z³), completing a 4- to 8-membered saturated, unsaturated or aromatic ring together with the carbon atoms to which they are attached; R⁶ is alkyl, alkenyl, alkynyl, alkoxy, cycloalkyl, cycloalkylalkyl, cycloalkenyl, cycloalkenylalkyl, aryl or aralkyl, any of which may be substituted with Z¹, Z² and Z³; R⁷ is (a) hydrogen; (b) alkyl, alkenyl, alkynyl, alkoxy, cycloalkyl, cycloalkylalkyl, cycloalkenyl, cycloalkenylalkyl, aryl or aralkyl, any of which may be substituted with Z¹, Z² and Z³; (c) cyano; (d) hydroxyl; (e) -C(O)H or -C(O)R⁶; (f) -CO₂R⁶; or (g) -SH, -S(O) n R⁶, -S(O) m -OR⁶, -O-S(O) m -R⁶ or -O-S(O) m -OR⁶, except when Z⁴ is -S(O) n -; R⁸ is (a) hydrogen; (b) -C(O)H or -C(O)R⁶, except when Z⁴ is -C(O)- and R⁷ is -C(O)H, -C(O)R⁶ or -CO₂R⁶; or (c) alkyl, alkenyl, alkynyl, alkoxy, cycloalkyl, cycloalkylalkyl, cycloalkenyl, cycloalkenylalkyl, aryl or aralkyl, any of which may be substituted with Z¹, Z² and Z³; or R⁷ and R⁸ together are alkylene or alkenylene (either of which may be substituted with Z¹, Z² and Z³), completing a 3- to 8-membered saturated, unsaturated or aromatic ring together with the nitrogen atom to which they are attached; R⁹ is (a) hydrogen; (b) hydroxyl; (c) -C(O)H or -C(O)R⁶; (d) -CO₂R⁶; (e) -SH, -S(O) n R⁶, -S(O) m -OR⁶, -O-S(O) m -R⁶ or -O-S(O) m -OR⁶; or (f) alkyl, alkenyl, alkynyl, alkoxy, cycloalkyl, cycloalkylalkyl, cycloalkenyl, cycloalkenylalkyl, aryl or aralkyl, any of which may be substituted with Z¹, Z² and Z³; R¹⁰ is (a) hydrogen; (b) -C(O)H or -C(O)R⁶, except when Z⁵ is -C(O)- and R⁹ is -C(O)H, -C(O)R⁶ or -CO₂R⁶; or (c) alkyl, alkenyl, alkynyl, alkoxy, cycloalkyl, cycloalkylalkyl, cycloalkenyl, cycloalkenylalkyl, aryl or aralkyl, any of which may be substituted with Z¹, Z² and Z³; R¹¹ is (a) hydrogen; (b) hydroxyl or -CO₂R⁶, except when one of R⁹ and R¹⁰ is hydroxyl or -CO₂R⁶; (c) -C(O)H or -C(O)R⁶; or (d) alkyl, alkenyl, alkynyl, alkoxy, cycloalkyl, cycloalkylalkyl, cycloalkenyl, cycloalkenylalkyl, aryl or aralkyl, any of which may be substituted with Z¹, Z² and Z³; or any two of R⁹, R¹⁰ and R¹¹ together are alkylene or alkenylene (either of which may be substituted with Z¹, Z² and Z³), completing a 3- to 8-membered saturated, unsaturated or aromatic ring together with the atoms to which they are attached; Z¹, Z² and Z³ are each independently (a) hydrogen; (b) halo; (c) hydroxy; (d) alkyl, alkenyl, aralkyl, alkoxy, aryloxy or aralkoxy; (e) -SH, -S(O) n Z⁶, -S(O) m -OH, -S(O) m -OZ⁶, -O-S(O) m -Z⁶, -O-S(O) m OH or -O-S(O) m -OZ⁶; (f) oxo; (g) nitro; (h) cyano; (i) -C(O)H or -C(O)Z⁶; (j) -CO₂H or -CO₂Z⁶; or (k) -Z⁴-NZ⁷Z⁸ Z⁴-N(Z¹¹)-Z⁵Z⁶ or -Z⁴-N(Z¹¹)-Z⁵-NZ⁷Z⁸; Z⁴ and Z⁵ are each independently (a) a single bond; (b) -Z⁹-S(O) m -Z¹⁰; (c) -Z⁹-C(O)-Z¹⁰; (d) -Z⁹-C(S)-Z¹⁰; (e) -Z⁹-O-Z¹⁰; (f) -Z⁹-S-Z¹⁰; (g) -Z⁹-O-C(O)-Z¹⁰; or (h) alkyl, alkenyl, alkynyl, cycloalkyl, cycloalkylalkyl, cycloalkenyl, cycloalkenylalkyl, aryl or aralkyl, any of which may be substituted with Z¹, Z² and Z³; Z⁶, Z⁷ and Z⁸ are each independently hydrogen, alkyl, alkenyl, alkynyl, cycloalkyl, cycloalkylalkyl, cycloalkenyl, cycloalkenylalkyl, aryl, or aralkyl, or Z⁷ and Z⁸ together are alkylene or alkenylene, completing a 3- to 8-membered saturated, unsaturated or aromatic ring together with the nitrogen atom to which they are attached; Z⁹ and Z¹⁰ are each independently a single bond, alkylene, alkenylene or alkynylene, Z¹¹ is (a) hydrogen; (b) hydroxyl; (c) -C(O)H, -C(O)Z⁶ or -CO₂Z⁶, provided that when Z¹¹ is -CO₂Z⁶, Z⁶ is other than hydrogen; or (d) alkyl, alkenyl, alkynyl, alkoxy, cycloalkyl, cycloalkylalkyl, cycloalkenyl, cycloalkenylalkyl, aryl or aralkyl; or any two of Z⁷, Z⁸ and Z¹¹ together are alkylene or alkenylene, completing a 3- to 8- membered saturated, unsaturated or aromatic ring together with the atoms to which they are attached; m is 1 or 2; and n is 0, 1 or 2.
Claim 3
Dependent Claim 30 words
The compound of Claim 1, wherein R is with the sulfonamide attached at position 1 or 2 and one of R¹, R² and R³ attached at position 5 or 6.
Claim 4
Dependent Claim 14 words
The compound of Claim 3, wherein one of R¹, R² and R³ is -NR⁷R⁸.
Claim 5
Dependent Claim 16 words
The compound of Claim 4, wherein R⁷ and R⁸ are each independently hydrogen, alkyl or C(O)alkyl.
Claim 6
Dependent Claim 17 words
The compound of Claim 5, wherein R⁷ and R⁸ are each independently hydrogen, methyl, methylethyl or acetyl.
Claim 7
Dependent Claim 16 words
The compound of Claim 3, wherein R⁴, R⁵ and R¹² are independently hydrogen, alkyl or halo.
Claim 8
Dependent Claim 8 words
The compound of Claim 1, having the formula
Claim 9
Dependent Claim 16 words
The compound of Claim 8, wherein R⁷ and R⁸ are each independently hydrogen, alkyl or C(O)alkyl.
Claim 10
Dependent Claim 17 words
The compound of Claim 9, wherein R⁷ and R⁸ are each independently hydrogen, methyl, methylethyl or acetyl.
Claim 11
Dependent Claim 18 words
The compound of Claim 1, wherein R is biphenyl which may be substituted with R¹, R² and R³.
Claim 12
Dependent Claim 17 words
The compound of Claim 11, wherein one of R¹, R² and R³ is 4'-alkyl or 4'-branched alkyl.
Claim 13
Dependent Claim 14 words
The compound of Claim 12, wherein one of R¹, R² and R³ is 4'-alkyl.
Claim 14
Dependent Claim 15 words
The compound of Claim 12, wherein one of R¹, R² and R³ is 4'-branched alkyl.
Claim 15
Dependent Claim 14 words
The compound of Claim 1, which is: N-(6-Chloro-3-pyridazinyl)-5-(dimethylamino)-1-naphthalenesulfonamide; N-(6-Chloro-5-methyl-3-pyridazinyl)-5-(dimethylamino)-1 -naphthalenesulfonamide; N-(6-Chloro-4-methyl-3-pyridazinyl)-5-(dimethylamino)-1-naphthalenesulfonamide; N-(6-Chloro-3-pyridazinyl)[1,1'-biphenyl]-2-yl-sulfonamide; or N-(6-Chloro-3-pyridazinyl)-4'-(2-methylpropyl)[1,1'-biphenyl]-2-sulfonamide.
Claim 16
Dependent Claim 26 words
Use of a compound of any one of Claims 1-15 for the manufacture of a medicament for the treatment of endothelin- related disorders in a mammal.
Claim 17
Dependent Claim 21 words
Use of a compound of any one of Claims 1-15 for the manufacture of a medicament for the treatment of hyper-tension.
Claim 18
Dependent Claim 26 words
Use of a compound of any one of Claims 1-15 for the manufacture of a medicament for the treatment of renal, glomerular or mesangial cell disorders.
Claim 19
Dependent Claim 21 words
Use of a compound of any one of Claims 1-15 for the manufacture of a medicament for the treatment of endotoxemia.
Claim 20
Dependent Claim 21 words
Use of a compound of any one of Claims 1-15 for the manufacture of a medicament for the treatment of ischemia.

References Cited (Backward Citations)

EP0510526A1 Cited
EP0526708A1 Cited
EP0558258A1 Cited
EP0569193A1 Cited

USPTO Annuity & Maintenance Windows

Maintenance schedule is calculated for granted US utility patents.

Assigned Categories & Tags

No categories assigned to this patent yet.

Assign Category Tag